| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,190 |
29,731 |
$2.21M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
7,880 |
7,153 |
$1.70M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,324 |
26,247 |
$1.12M |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,325 |
2,864 |
$242K |
| 80053 |
Comprehensive metabolic panel |
23,533 |
20,048 |
$233K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,281 |
1,131 |
$201K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,306 |
2,103 |
$199K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,971 |
21,219 |
$195K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,578 |
10,471 |
$125K |
| 87081 |
|
13,070 |
12,138 |
$122K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
10,536 |
9,150 |
$109K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,956 |
4,369 |
$108K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
950 |
881 |
$98K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,204 |
4,052 |
$94K |
| 71045 |
Radiologic examination, chest; single view |
13,229 |
11,461 |
$66K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
926 |
803 |
$60K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,145 |
970 |
$53K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
361 |
148 |
$47K |
| 87430 |
|
2,521 |
2,292 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,954 |
2,667 |
$39K |
| 84484 |
|
5,126 |
4,320 |
$38K |
| 83690 |
|
5,469 |
4,753 |
$36K |
| 97597 |
|
1,385 |
540 |
$33K |
| 81025 |
|
8,593 |
7,568 |
$29K |
| 81003 |
|
11,509 |
9,677 |
$27K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
679 |
305 |
$26K |
| 81001 |
|
5,093 |
4,472 |
$20K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
453 |
407 |
$13K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
669 |
422 |
$13K |
| 83605 |
|
1,240 |
1,072 |
$12K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
225 |
189 |
$10K |
| 59025 |
Fetal non-stress test |
2,091 |
1,139 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
234 |
222 |
$9K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
17 |
13 |
$9K |
| 80306 |
|
914 |
718 |
$9K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
108 |
96 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
898 |
777 |
$8K |
| 83880 |
|
272 |
225 |
$8K |
| 83735 |
|
843 |
728 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
159 |
145 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
388 |
345 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
859 |
790 |
$5K |
| 85610 |
|
1,493 |
1,254 |
$5K |
| 84439 |
|
559 |
499 |
$5K |
| 87186 |
|
425 |
363 |
$4K |
| 86592 |
|
610 |
549 |
$4K |
| 87040 |
|
354 |
276 |
$4K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
74 |
70 |
$4K |
| 82607 |
|
249 |
236 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
114 |
97 |
$4K |
| 85027 |
|
598 |
533 |
$4K |
| 0002A |
|
121 |
111 |
$3K |
| 87077 |
|
336 |
284 |
$3K |
| 0001A |
|
131 |
122 |
$3K |
| 87806 |
|
107 |
99 |
$3K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
19 |
14 |
$3K |
| 82150 |
|
468 |
407 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,647 |
2,305 |
$3K |
| 87807 |
|
238 |
220 |
$3K |
| 86762 |
|
102 |
93 |
$2K |
| 86803 |
|
105 |
96 |
$2K |
| 95811 |
|
14 |
12 |
$2K |
| 87340 |
|
124 |
109 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
805 |
666 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
39 |
12 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
235 |
222 |
$2K |
| 81015 |
|
609 |
547 |
$2K |
| 86709 |
|
91 |
83 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,735 |
4,776 |
$1K |
| 85730 |
|
876 |
741 |
$1K |
| 86850 |
|
186 |
163 |
$1K |
| 86900 |
|
365 |
318 |
$1K |
| 86901 |
|
365 |
318 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
639 |
535 |
$1K |
| 87070 |
|
62 |
53 |
$794.01 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
82 |
67 |
$707.93 |
| 80061 |
Lipid panel |
27 |
25 |
$529.69 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
13 |
$500.30 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
59 |
56 |
$480.87 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
23 |
14 |
$413.03 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12 |
12 |
$358.82 |
| 82947 |
|
59 |
52 |
$319.28 |
| 82247 |
|
63 |
51 |
$305.55 |
| 83655 |
|
16 |
13 |
$266.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
557 |
456 |
$264.48 |
| 84481 |
|
16 |
16 |
$257.55 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
118 |
77 |
$216.80 |
| 84466 |
|
12 |
12 |
$207.02 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$205.26 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
152 |
121 |
$186.98 |
| 72100 |
|
16 |
14 |
$179.37 |
| 84702 |
|
14 |
13 |
$171.90 |
| 82746 |
|
12 |
12 |
$159.06 |
| 82728 |
|
12 |
12 |
$123.31 |
| 82550 |
|
15 |
13 |
$114.03 |
| 83540 |
|
12 |
12 |
$85.03 |
| 85380 |
|
13 |
13 |
$82.95 |
| 85044 |
|
12 |
12 |
$69.52 |
| 84436 |
|
12 |
12 |
$53.10 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
25 |
25 |
$19.28 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
485 |
368 |
$12.00 |
| 36415 |
Collection of venous blood by venipuncture |
6,333 |
5,064 |
$6.24 |
| 82962 |
|
114 |
66 |
$2.85 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,084 |
837 |
$0.35 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
118 |
66 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
133 |
78 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
36 |
26 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
81 |
75 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
43 |
27 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
82 |
71 |
$0.00 |
| 80320 |
|
122 |
83 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
54 |
45 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
15 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
144 |
132 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
169 |
102 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
15 |
12 |
$0.00 |